Showing 66,401 - 66,420 results of 108,732 for search '(( a point decrease ) OR ( 5 ((((ng decrease) OR (a decrease))) OR (we decrease)) ))', query time: 1.93s Refine Results
  1. 66401

    β-Catenin regulates proliferation of prostatic duct progenitors. by Jeffrey C. Francis (107011)

    Published 2013
    “…A significant decrease in proliferation is evident after 5 days in culture, compared to control prostates (E18.5 p = 0.095, 5 days in culture p = 0.0016). …”
  2. 66402

    101 flagellate phylogenomics data by Guifré Torruella (3846172)

    Published 2024
    “…Neither with marine and freshwater organisms, nor between large and small apusomonads. Interestingly, we found that the subset of only eukaryote peptides reported from ~30% of BUSCO completeness using the bacteria db10 in Chelonemonas geobuk, up to 50% in Mylnikovia oxoniensis; a similar value found in the previously sequenced Thecamonas trahens refseq proteins (47.5%). …”
  3. 66403

    Quantitative Analysis of Cleavage Orientation by Marcus Bischoff (274400)

    Published 2013
    “…The point where this vector hits a target screen is marked by a dot (the distance between mother cell and screen along the a-p axis is normalised to 1). …”
  4. 66404

    Google form data_ Public awareness and acceptance of COVID-19 vaccine: An online cross-sectional survey, conducted in the first phase of vaccination drive in India by Arumuganainar Suresh (10582049)

    Published 2021
    “…A total of 3 questions for acceptance (Table 3) were prepared and rated on the 5-points Likert scale ranging from strongly disagree (1), disagree (2), neutral (3), agree (4) and strongly agree (5). …”
  5. 66405

    Image_2_The S2–S3 Loop of Kv7.4 Channels Is Essential for Calmodulin Regulation of Channel Activation.tif by Wenhui Zhuang (10007378)

    Published 2021
    “…Kv7.4 channels co-expressed with wild-type (WT) CaM show inhibited activation when intracellular calcium levels increase, while Kv7.4 channels co-expressed with CaM<sub>1234</sub> or CaM<sub>3</sub> are insensitive to calcium. Mutations C156A, C157A, C158V, R159, and R161A, which are located within the Kv7.4 S2–S3 loop, dramatically facilitate activation of Kv7.4 channels co-expressed with WT CaM but have no effect on activation of Kv7.4 channels co-expressed with CaM<sub>3</sub>, indicating that these five mutations decrease the inhibitory effect of Ca<sup>2+</sup>/CaM. …”
  6. 66406

    Image_7_The S2–S3 Loop of Kv7.4 Channels Is Essential for Calmodulin Regulation of Channel Activation.tif by Wenhui Zhuang (10007378)

    Published 2021
    “…Kv7.4 channels co-expressed with wild-type (WT) CaM show inhibited activation when intracellular calcium levels increase, while Kv7.4 channels co-expressed with CaM<sub>1234</sub> or CaM<sub>3</sub> are insensitive to calcium. Mutations C156A, C157A, C158V, R159, and R161A, which are located within the Kv7.4 S2–S3 loop, dramatically facilitate activation of Kv7.4 channels co-expressed with WT CaM but have no effect on activation of Kv7.4 channels co-expressed with CaM<sub>3</sub>, indicating that these five mutations decrease the inhibitory effect of Ca<sup>2+</sup>/CaM. …”
  7. 66407

    Image_4_The S2–S3 Loop of Kv7.4 Channels Is Essential for Calmodulin Regulation of Channel Activation.tif by Wenhui Zhuang (10007378)

    Published 2021
    “…Kv7.4 channels co-expressed with wild-type (WT) CaM show inhibited activation when intracellular calcium levels increase, while Kv7.4 channels co-expressed with CaM<sub>1234</sub> or CaM<sub>3</sub> are insensitive to calcium. Mutations C156A, C157A, C158V, R159, and R161A, which are located within the Kv7.4 S2–S3 loop, dramatically facilitate activation of Kv7.4 channels co-expressed with WT CaM but have no effect on activation of Kv7.4 channels co-expressed with CaM<sub>3</sub>, indicating that these five mutations decrease the inhibitory effect of Ca<sup>2+</sup>/CaM. …”
  8. 66408

    Image_6_The S2–S3 Loop of Kv7.4 Channels Is Essential for Calmodulin Regulation of Channel Activation.tif by Wenhui Zhuang (10007378)

    Published 2021
    “…Kv7.4 channels co-expressed with wild-type (WT) CaM show inhibited activation when intracellular calcium levels increase, while Kv7.4 channels co-expressed with CaM<sub>1234</sub> or CaM<sub>3</sub> are insensitive to calcium. Mutations C156A, C157A, C158V, R159, and R161A, which are located within the Kv7.4 S2–S3 loop, dramatically facilitate activation of Kv7.4 channels co-expressed with WT CaM but have no effect on activation of Kv7.4 channels co-expressed with CaM<sub>3</sub>, indicating that these five mutations decrease the inhibitory effect of Ca<sup>2+</sup>/CaM. …”
  9. 66409

    Image_8_The S2–S3 Loop of Kv7.4 Channels Is Essential for Calmodulin Regulation of Channel Activation.tif by Wenhui Zhuang (10007378)

    Published 2021
    “…Kv7.4 channels co-expressed with wild-type (WT) CaM show inhibited activation when intracellular calcium levels increase, while Kv7.4 channels co-expressed with CaM<sub>1234</sub> or CaM<sub>3</sub> are insensitive to calcium. Mutations C156A, C157A, C158V, R159, and R161A, which are located within the Kv7.4 S2–S3 loop, dramatically facilitate activation of Kv7.4 channels co-expressed with WT CaM but have no effect on activation of Kv7.4 channels co-expressed with CaM<sub>3</sub>, indicating that these five mutations decrease the inhibitory effect of Ca<sup>2+</sup>/CaM. …”
  10. 66410

    Image_9_The S2–S3 Loop of Kv7.4 Channels Is Essential for Calmodulin Regulation of Channel Activation.tif by Wenhui Zhuang (10007378)

    Published 2021
    “…Kv7.4 channels co-expressed with wild-type (WT) CaM show inhibited activation when intracellular calcium levels increase, while Kv7.4 channels co-expressed with CaM<sub>1234</sub> or CaM<sub>3</sub> are insensitive to calcium. Mutations C156A, C157A, C158V, R159, and R161A, which are located within the Kv7.4 S2–S3 loop, dramatically facilitate activation of Kv7.4 channels co-expressed with WT CaM but have no effect on activation of Kv7.4 channels co-expressed with CaM<sub>3</sub>, indicating that these five mutations decrease the inhibitory effect of Ca<sup>2+</sup>/CaM. …”
  11. 66411

    Data_Sheet_1_4DEMON: Integrating 40 Years of Data on PCB and Metal Contamination in Marine Sediments of the Belgian Part of the North Sea.docx by Hong Minh Le (10887786)

    Published 2021
    “…Trend analysis revealed a strong decrease in PCB concentrations in the nineteen eighties and nineties, followed by a slight increase over the last decade. …”
  12. 66412

    Image_1_The S2–S3 Loop of Kv7.4 Channels Is Essential for Calmodulin Regulation of Channel Activation.tif by Wenhui Zhuang (10007378)

    Published 2021
    “…Kv7.4 channels co-expressed with wild-type (WT) CaM show inhibited activation when intracellular calcium levels increase, while Kv7.4 channels co-expressed with CaM<sub>1234</sub> or CaM<sub>3</sub> are insensitive to calcium. Mutations C156A, C157A, C158V, R159, and R161A, which are located within the Kv7.4 S2–S3 loop, dramatically facilitate activation of Kv7.4 channels co-expressed with WT CaM but have no effect on activation of Kv7.4 channels co-expressed with CaM<sub>3</sub>, indicating that these five mutations decrease the inhibitory effect of Ca<sup>2+</sup>/CaM. …”
  13. 66413

    Image_3_The S2–S3 Loop of Kv7.4 Channels Is Essential for Calmodulin Regulation of Channel Activation.tif by Wenhui Zhuang (10007378)

    Published 2021
    “…Kv7.4 channels co-expressed with wild-type (WT) CaM show inhibited activation when intracellular calcium levels increase, while Kv7.4 channels co-expressed with CaM<sub>1234</sub> or CaM<sub>3</sub> are insensitive to calcium. Mutations C156A, C157A, C158V, R159, and R161A, which are located within the Kv7.4 S2–S3 loop, dramatically facilitate activation of Kv7.4 channels co-expressed with WT CaM but have no effect on activation of Kv7.4 channels co-expressed with CaM<sub>3</sub>, indicating that these five mutations decrease the inhibitory effect of Ca<sup>2+</sup>/CaM. …”
  14. 66414

    Nefopam inhibits cell viability in cultures from aggressive fibromatosis and hypertrophic cutaneous wounds. by Raymond Poon (12265)

    Published 2013
    “…Treatment with carrier alone gave identical results as for diphenhydramine. An asterisk over a data point indicates a significant difference form the control cell cultures.…”
  15. 66415

    Spike timing dependent plasticity. by Collins Assisi (316086)

    Published 2020
    “…<p>The post–synaptic neuron (red) spikes follow that of the pre–synaptic neuron (black), leading to an increase in the synaptic weight (facilitation) (Fig 5A top panel). The opposite temporal order (post–synaptic spikes occur before pre–synaptic spikes) leads to a decrease in synaptic weights (depression) (Fig 5A bottom panel). …”
  16. 66416
  17. 66417

    Data_Sheet_1_Supplementation with inulin reverses cognitive flexibility alterations and modulates the gut microbiota in high-fat-fed mice.docx by Gabriela González-Velázquez (20131497)

    Published 2024
    “…Statistically significant differences in alpha diversity for gut microbiota were observed using the Shannon, Simpson, and Chao1 indices. The I group showed a decrease in bacterial diversity compared to the HF group. …”
  18. 66418

    Table_1_Nocebo Effects of Clinical Communication and Placebo Effects of Positive Suggestions on Respiratory Muscle Strength.DOCX by Nina Zech (3601097)

    Published 2022
    “…After risk information, a decrease was observed in three of the parameters, with the highest extend in expiratory pressure by 4.4%. …”
  19. 66419

    Data_Sheet_2_Exercise Capacity Is Improved by Levosimendan in Heart Failure and Sarcopenia via Alleviation of Apoptosis of Skeletal Muscle.xlsx by Di Wang (329735)

    Published 2022
    “…Therefore, levosimendan may be a potential drug for the treatment of heart failure with sarcopenia.…”
  20. 66420

    Data_Sheet_1_Exercise Capacity Is Improved by Levosimendan in Heart Failure and Sarcopenia via Alleviation of Apoptosis of Skeletal Muscle.PDF by Di Wang (329735)

    Published 2022
    “…Therefore, levosimendan may be a potential drug for the treatment of heart failure with sarcopenia.…”